IV ketamine for Coral Springs — psychiatry-supervised, integrated with therapy.

For Coral Springs, Parkland, and Heron Bay families, RECO Health's Delray Beach campus is 25 miles and about 35 minutes south — close enough to make a six-infusion induction across two to three weeks logistically workable. IV ketamine at RECO is psychiatry-supervised, delivered in a monitored clinical setting with continuous vitals and CADSS scoring, and paired with therapist-led integration sessions the day after each infusion. Both IV racemic ketamine and Spravato (esketamine) are offered; the choice is made with a board-certified psychiatrist during the initial consult, weighing insurance coverage, schedule, and clinical fit.

Coral Springs sits 25 miles inland from RECO Health’s Delray Beach campus — roughly 35 minutes via the Sawgrass Expressway and I-95. For families in Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, and Heron Bay, that drive puts a specialist-level psychiatric infusion program within reasonable reach — one that treats IV ketamine therapy as a psychiatry-supervised medical intervention integrated with therapy, not a standalone infusion booked without a prescriber. This page describes how the service is delivered, when it is indicated, and how the choice between IV ketamine and Spravato is made.

Ketamine’s mechanism and why it works fast

Ketamine is a non-competitive NMDA receptor antagonist. Blockade of NMDA receptors on GABAergic interneurons produces a downstream disinhibition of glutamate release, which in turn activates AMPA receptors, triggers BDNF release, and drives rapid synaptogenesis in the medial prefrontal cortex and hippocampus. Preclinical work — and the human PET and structural imaging that followed — has consistently shown restoration of dendritic spine density in the regions implicated in depression within 24 hours of a single infusion.

Unlike SSRIs such as sertraline, escitalopram, or fluoxetine, which act on monoamine reuptake and require four to six weeks to produce a measurable clinical response, ketamine’s antidepressant and anti-suicidal effect emerges within hours to days. That kinetic profile is why ketamine has a specific place in the treatment-resistant depression pathway — patients who have failed two or more adequate antidepressant trials, often augmented with lithium, aripiprazole, or quetiapine — and in the acute suicidality pathway, where a six-week onset is not clinically acceptable. Ketamine is not a first-line agent for major depressive disorder; it is a rescue and consolidation option for the patients where standard pharmacology has already failed.

The 40-minute infusion, monitored recovery, and the six-session induction

Each session runs roughly two hours end-to-end. Clients arrive, complete a brief pre-infusion assessment including PHQ-9 and vital signs, and are seated in a recliner in a monitored infusion room. The infusion itself is 0.5 mg/kg of racemic ketamine delivered over 40 minutes via IV pump, weight-adjusted and occasionally titrated upward in later sessions based on prior response and tolerance. Blood pressure, heart rate, and continuous pulse oximetry are tracked throughout; transient hypertension and mild tachycardia are expected and rarely require intervention. Dissociative symptoms are assessed with the Clinician-Administered Dissociative States Scale (CADSS) at the midpoint and post-infusion.

Monitored recovery runs 30 to 60 minutes until vitals and orientation return to baseline. Clients cannot drive after an infusion and must arrange transport; Coral Springs families typically coordinate a family driver or ride-share for the trip home. The induction series is six infusions across two to three weeks — the window where sustained response either consolidates or does not. Response is tracked with weekly PHQ-9 and GAD-7. Maintenance boosters are scheduled based on how long the initial response holds; some clients need one at four weeks, others at three to six months.

Integration with psychotherapy makes response durable

Ketamine opens a window; therapy determines whether the client walks through it. RECO’s protocol pairs the infusion series with therapist-led integration sessions — typically the day after each infusion — where the clinician works with the affective and cognitive material that surfaced during the dissociative state and consolidates the shifts into durable change. Integration draws on cognitive behavioral therapy, acceptance and commitment therapy, and, where trauma is the driving pathology, EMDR.

Ketamine delivered without integration produces measurably shorter response duration and higher relapse rates in the published literature. That is why RECO does not offer standalone infusion packages: the medication is treated as a catalyst that requires structured psychotherapy to convert an acute pharmacological response into lasting change in mood, cognition, and behavior. Clients continue with an outside therapist where clinically appropriate; where they do not have one, RECO’s outpatient program provides the integration therapist directly and coordinates with the prescribing psychiatrist so the medication and therapy tracks stay aligned.

IV ketamine vs Spravato — how the decision is made

Two forms of ketamine exist in psychiatry. IV racemic ketamine is off-label for depression and is typically cash-pay. Spravato (esketamine) is the FDA-approved intranasal formulation for treatment-resistant depression, covered by most commercial insurance under a REMS protocol that requires in-clinic administration and a two-hour monitored observation after each dose. The choice between them is both clinical and financial.

Spravato is the right choice when insurance coverage is the deciding factor, when the client can commit to twice-weekly dosing for the first four weeks followed by weekly and then biweekly maintenance, and when the intranasal route is acceptable. IV ketamine is the right choice when dose flexibility matters — for clients whose response requires titration above the 0.5 mg/kg baseline — when a compressed induction schedule is preferred, and when the treating psychiatrist judges that racemic ketamine’s pharmacology fits the case better than the S-enantiomer alone. RECO offers both, and the decision is made with the client during the initial psychiatry consult, with cost, schedule, and clinical fit weighed together.

What to expect on your first visit

The first visit is a 60- to 90-minute psychiatry consult, not an infusion. The consulting psychiatrist reviews diagnostic history, prior antidepressant and augmenting trials — dose, duration, response, and reason for discontinuation — and any prior ECT, TMS, or ketamine exposure. Baseline PHQ-9, GAD-7, and the Columbia Suicide Severity Rating Scale are administered. Medical clearance addresses uncontrolled hypertension, active psychotic symptoms, and current substance use, each of which affects candidacy or timing.

If ketamine is indicated, the psychiatrist explains the induction schedule, the integration therapy structure, and the choice between IV ketamine and Spravato. First infusions are typically scheduled within a week. Clients who are also managing a substance use disorder are stabilized on medication-assisted treatment — buprenorphine or naltrexone as clinically appropriate — before ketamine begins, since active untreated withdrawal is a contraindication to a dissociative infusion.

Insurance and admissions from Coral Springs

RECO Health verifies benefits with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS in advance of the initial consult and provides Coral Springs families with a written estimate for both the IV ketamine and the Spravato pathways before the first appointment. IV racemic ketamine is generally not covered by commercial insurance and is billed as cash-pay; Spravato is usually covered, and admissions coordinators handle the REMS enrollment where esketamine is the chosen route.

Same-week evaluations are typical. The drive from Coral Springs is 25 miles and roughly 35 minutes via the Sawgrass Expressway and I-95, and infusion appointments are scheduled to avoid the worst of the southbound morning commute — a small logistical detail that matters over the course of a six-session induction.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.